FindTrial
Sign In

Endophthalmitis Management Study

"The Endophthalmitis Management (EMS):The results of inflammatory score based management of post operative endophthalmitis"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017876
Enrollment
128
Registered
2019-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H308- Other chorioretinal inflammations

Interventions

Intervention1: Intravitreal Antibiotics: Empirically one arm will be injected with intavitreal vancomycin + Ceftazidime and other arm will be injected with vancomycin + Imipenem. If fungus is detected

Sponsors

L V Prasad Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinical signs and/or symptoms of endophthalmitis (bacterial and fungal) 2. Post surgical endophthalmitis cases following any intraocular surgery 3. Visual acuity from 6/12 to Light perception 4 Signed consent

Exclusion criteria

Exclusion criteria: 1.Patient 18 years or younger 2. One eyed person 3. Unfit for surgery 4. Retina detached at time of presentation (indirect ophthalmoscopy/ ultrasonography) 5.Lack of signed consent

Design outcomes

Primary

MeasureTime frame
Improvement of BCVA at one month by 2 lines or moreTimepoint: 1 Month—

Secondary

MeasureTime frame
1.Decrease in Inflammatory score at the end of 1 month 2.Retinal detachment any time within 3 months 3.Hypotony 5 mm Hg between 1- 3 months 4.Loss of BCVA by 2 lines or more at the end of 1 month Timepoint: 1 Month—

Countries

India

Contacts

Public ContactDr Vivek Dave

LV Prasad Eye Institute

vivekdave@lvpei.org04030612656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026